| Clinical use of dendritic cells for cancer therapy S Anguille, EL Smits, E Lion, VF van Tendeloo, ZN Berneman The lancet oncology 15 (7), e257-e267, 2014 | 802 | 2014 |
| Induction of complete and molecular remissions in acute myeloid leukemia by Wilms’ tumor 1 antigen-targeted dendritic cell vaccination VF Van Tendeloo, A Van de Velde, A Van Driessche, N Cools, S Anguille, ... Proceedings of the National Academy of Sciences 107 (31), 13824-13829, 2010 | 482 | 2010 |
| Cilta-cel or standard care in lenalidomide-refractory multiple myeloma J San-Miguel, B Dhakal, K Yong, A Spencer, S Anguille, MV Mateos, ... New England Journal of Medicine 389 (4), 335-347, 2023 | 303 | 2023 |
| Leukemia-associated antigens and their relevance to the immunotherapy of acute myeloid leukemia S Anguille, VF Van Tendeloo, ZN Berneman Leukemia 26 (10), 2186-2196, 2012 | 219 | 2012 |
| Bisphosphonates for cancer treatment: mechanisms of action and lessons from clinical trials HH Van Acker, S Anguille, Y Willemen, EL Smits, VF Van Tendeloo Pharmacology & therapeutics 158, 24-40, 2016 | 217 | 2016 |
| Dendritic cell vaccination as postremission treatment to prevent or delay relapse in acute myeloid leukemia S Anguille, AL Van de Velde, EL Smits, VF Van Tendeloo, G Juliusson, ... Blood, The Journal of the American Society of Hematology 130 (15), 1713-1721, 2017 | 216 | 2017 |
| Dendritic cells as pharmacological tools for cancer immunotherapy S Anguille, EL Smits, C Bryant, HH Van Acker, H Goossens, E Lion, ... Pharmacological reviews 67 (4), 731-753, 2015 | 182 | 2015 |
| Safety and clinical efficacy of BCMA CAR-T-cell therapy in multiple myeloma G Roex, M Timmers, K Wouters, D Campillo-Davo, D Flumens, ... Journal of hematology & oncology 13, 1-14, 2020 | 151 | 2020 |
| Interferon-α in acute myeloid leukemia: an old drug revisited S Anguille, E Lion, Y Willemen, VFI Van Tendeloo, ZN Berneman, E Smits Leukemia 25 (5), 739-748, 2011 | 133 | 2011 |
| Interleukin-15 enhances the proliferation, stimulatory phenotype, and antitumor effector functions of human gamma delta T cells HH Van Acker, S Anguille, Y Willemen, JM Van den Bergh, ZN Berneman, ... Journal of hematology & oncology 9, 1-13, 2016 | 122 | 2016 |
| Effect of anti-interleukin drugs in patients with COVID-19 and signs of cytokine release syndrome (COV-AID): a factorial, randomised, controlled trial J Declercq, KFA Van Damme, E De Leeuw, B Maes, C Bosteels, ... The Lancet Respiratory Medicine 9 (12), 1427-1438, 2021 | 121 | 2021 |
| mRNA-based dendritic cell vaccination induces potent antiviral T-cell responses in HIV-1-infected patients E Van Gulck, E Vlieghe, M Vekemans, VFI Van Tendeloo, A Van De Velde, ... Aids 26 (4), F1-F12, 2012 | 118 | 2012 |
| Short-term cultured, interleukin-15 differentiated dendritic cells have potent immunostimulatory properties S Anguille, ELJM Smits, N Cools, H Goossens, ZN Berneman, ... Journal of translational medicine 7, 1-16, 2009 | 118 | 2009 |
| Human plasmacytoid dendritic cells are equipped with antigen-presenting and tumoricidal capacities J Tel, EL Smits, S Anguille, RN Joshi, CG Figdor, IJM de Vries Blood, The Journal of the American Society of Hematology 120 (19), 3936-3944, 2012 | 112 | 2012 |
| Chimeric antigen receptor-modified T cell therapy in multiple myeloma: beyond B cell maturation antigen M Timmers, G Roex, Y Wang, D Campillo-Davo, VFI Van Tendeloo, Y Chu, ... Frontiers in immunology 10, 1613, 2019 | 95 | 2019 |
| Reduced humoral immune response after BNT162b2 coronavirus disease 2019 messenger RNA vaccination in cancer patients under antineoplastic treatment M Peeters, L Verbruggen, L Teuwen, G Vanhoutte, SV Kerckhove, ... ESMO open 6 (5), 100274, 2021 | 90 | 2021 |
| Dendritic cell-based cancer gene therapy ELJM Smits, S Anguille, N Cools, ZN Berneman, VFI Van Tendeloo Human gene therapy 20 (10), 1106-1118, 2009 | 87 | 2009 |
| Tumoricidal activity of human dendritic cells J Tel, S Anguille, CEJ Waterborg, EL Smits, CG Figdor, IJM de Vries Trends in immunology 35 (1), 38-46, 2014 | 82 | 2014 |
| Empowering gamma delta T cells with antitumor immunity by dendritic cell-based immunotherapy HH Van Acker, S Anguille, VF Van Tendeloo, E Lion Oncoimmunology 4 (8), e1021538, 2015 | 75 | 2015 |
| Dendritic cell-based immunotherapy of acute myeloid leukemia HH Van Acker, M Versteven, FS Lichtenegger, G Roex, D Campillo-Davo, ... Journal of clinical medicine 8 (5), 579, 2019 | 73 | 2019 |
